RAD LOSS ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – RAD
April 22, 2023 20:32 ET
|
The Rosen Law Firm PA
NEW YORK, April 22, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 26, 2018...
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – RAD
March 31, 2023 12:23 ET
|
The Rosen Law Firm PA
NEW YORK, March 31, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 26, 2018...
Insights on the Opioid Use Disorder Global Market to 2031 - by Drug Type, Age Group, Route of Administration, Distribution Channel and Region
November 04, 2022 06:28 ET
|
Research and Markets
Dublin, Nov. 04, 2022 (GLOBE NEWSWIRE) -- The "Opioid Use Disorder Market: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's...
Opioid Analgesics Market is Forecast to Reach a Valuation of US$ 69.55 billion in 2032, at a 5.4% CAGR | Future Market Insights, Inc.
September 20, 2022 06:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The global opioid analgesics market is projected to reach a value of US$ 69.55 Bn in 2032, with the market expanding at a steady CAGR of 5.4% from the...
Addinex Technologies Awarded $260K Grant by the CDC to Improve Addiction Medication Dispensing
September 07, 2022 08:00 ET
|
Addinex Technologies, Inc.
NEW YORK, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Addinex Technologies, Inc., a healthcare technology company focused on the innovation of medication dispensing, has been awarded a $260K Phase I Small...
Protega Pharmaceuticals™ LLC Announces Commercialization of RoxyBond™ (oxycodone hydrochloride) Tablets CII in the U.S.
July 06, 2022 08:00 ET
|
Protega Pharmaceuticals LLC
RoxyBond is the first and only immediate-release opioid medication with FDA-approved labeling describing abuse-deterrent properties.1 PRINCETON, N.J., July 06, 2022 (GLOBE NEWSWIRE) -- Protega...
The Worldwide Opioids Industry is Expected to Reach $5.4 Billion by 2027
June 23, 2022 07:18 ET
|
Research and Markets
Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Global Opioids Market Size, Share & Industry Trends Analysis Report By Application, By Product Type, By Regional Outlook and Forecast, 2021-2027"...
Insights on the Analgesics Global Market to 2027 - by Type, Drug Class, Route of Administration, Pain Type, Application and Region
June 15, 2022 07:43 ET
|
Research and Markets
Dublin, June 15, 2022 (GLOBE NEWSWIRE) -- The "Analgesics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...
Global Opioids Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
June 09, 2022 07:58 ET
|
Research and Markets
Dublin, June 09, 2022 (GLOBE NEWSWIRE) -- The "Opioids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...
Global Opioids Market Report to 2030 - Opportunity Analysis and Industry Forecasts
May 05, 2022 07:23 ET
|
Research and Markets
Dublin, May 05, 2022 (GLOBE NEWSWIRE) -- The "Opioids Market by Product Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...